First-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor
Deadline:31 May 2024, 00:00 CEST
Tender information
TED EULeipzig, Germany
- Type
- 16
- Procedure
- neg-w-call
- Ref. number
- 274800-2024
- CPV
- 85145000
The contract to be awarded is for a CRO to conduct a multicenter, first-in-human Phase I dose-escalation study of an antibody-based immunotherapy in patients with solid tumors